Clinical trials
Enrolling by invitation Phase 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| QED Therapeutics, a BridgeBio company | 2 |
| Sanofi | 2 |
| Autolus Limited | 1 |
| BioMarin Pharmaceutical | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Eledon Pharmaceuticals | 1 |
| Glycomine, Inc. | 1 |
| Gyroscope Therapeutics Limited | 1 |
| Immunovant Sciences GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 3 |
| Muscular Dystrophy, Duchenne | 3 |
| Musculoskeletal Diseases | 3 |
| Bone Diseases | 2 |
| Mucopolysaccharidosis IV | 2 |
| Osteochondrodysplasias | 2 |
| Achondroplasia | 1 |
| Anetoderma | 1 |
| Asthma | 1 |
| Drug Resistant Epilepsy | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.